Lexston Life Sciences Corp. (LEXT.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -648.32 Thousand CAD | 22.98% |
| 2022 | -841.73 Thousand CAD | 38.79% |
| 2021 | -1.88 Million CAD | -1350.93% |
| 2020 | -479.81 Thousand CAD | -1362.58% |
| 2019 | -6480.00 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -479.68 Thousand CAD | -350.74% |
| 2023 Q3 | -366.11 Thousand CAD | -178.19% |
| 2023 Q2 | -131.6 Thousand CAD | -24.39% |
| 2023 Q1 | -105.79 Thousand CAD | -115.21% |
| 2023 Q4 | -106.42 Thousand CAD | 70.93% |
| 2022 Q3 | -298.34 Thousand CAD | -506.9% |
| 2022 Q2 | -49.15 Thousand CAD | 82.48% |
| 2022 Q1 | -280.61 Thousand CAD | -322.03% |
| 2022 FY | - CAD | 24.08% |
| 2022 Q4 | -49.15 Thousand CAD | 83.52% |
| 2021 Q4 | 126.38 Thousand CAD | 138.71% |
| 2021 Q3 | -326.47 Thousand CAD | 48.5% |
| 2021 Q2 | -633.89 Thousand CAD | -20.11% |
| 2021 FY | - CAD | -1350.93% |
| 2021 Q1 | -527.74 Thousand CAD | 0.0% |
| 2020 Q3 | 119 Thousand CAD | 835.97% |
| 2020 Q2 | -16.17 Thousand CAD | 0.0% |
| 2020 FY | - CAD | -1362.58% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -4.98 Million CAD | 86.985% |
| Asep Medical Holdings Inc | -8.13 Million CAD | 92.031% |
| BetterLife Pharma Inc. | -3.19 Million CAD | 79.686% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 91.566% |
| ChitogenX Inc. | -2.69 Million CAD | 75.935% |
| Rapid Dose Therapeutics Corp. | -3.02 Million CAD | 78.566% |
| Defence Therapeutics Inc. | -12.67 Million CAD | 94.885% |
| Entheon Biomedical Corp. | 13.99 Thousand CAD | 4733.202% |
| Gemina Laboratories Ltd. | -5.17 Million CAD | 87.474% |
| Glow Lifetech Corp. | -1.26 Million CAD | 48.67% |
| Pharmala Biotech Holdings Inc. | -710.18 Thousand CAD | 8.711% |
| Doseology Sciences Inc. | -319.47 Thousand CAD | -102.932% |
| MYND Life Sciences Inc. | -1.82 Million CAD | 64.479% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | 46.076% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 78.697% |
| PreveCeutical Medical Inc. | -955.08 Thousand CAD | 32.119% |
| Telescope Innovations Corp. | -5.49 Million CAD | 88.192% |